Tiffany Sullivan
CIK: 0001876368
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LUNG
Pulmonx Corp
Director
Discretionary Trading P&L
Holdings
About Sullivan Tiffany
Sullivan Tiffany (SEC CIK 0001876368) files insider reports with the SEC as Director of Pulmonx Corp (LUNG).
Signal8 holds 2 ownership filings by Sullivan Tiffany, all Form 4s, filed between Jun 4, 2025 and Jun 9, 2026. Those filings report 2 transactions, from Jun 2, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sullivan Tiffany's filings is in REDWOOD CITY, CA.
Recent filings by Sullivan Tiffany
Other insiders filing for Pulmonx Corp (LUNG)
- French Glendon E. III, President and CEO
- Radhakrishnan Srikanth, Chief Science & Techn. Officer
- Lehman David Aaron, General Counsel
- Rose Geoffrey Beran, Chief Commercial Officer
- Burns Thomas William, Director
- Ferrari Richard, Director